Reduce pet owner costs, and increase revenue for your practice? A revolution in cancer detection saves lives and yields gains.

Imagine turning routine lump checks into one of your clinic’s most powerful diagnostic and financial tools.
That’s exactly what practices across the world are discovering with HT Vista, a non-invasive, AI-powered device designed to detect dermal and subcutaneous lumps in dogs with speed, accuracy, and ease. Beyond the clinical edge, it’s also delivering substantial business results.
If you’re a forward-thinking vet, HT Vista isn’t just a smart investment; it’s your next competitive advantage.
The Problem: Missed Opportunities in Early Detection
We know that 50% of dogs over the age of ten will be diagnosed with cancer in their lifetime. And even more walk through your doors with unexplored lumps and bumps — many of which never go beyond palpation or “wait and see.” It’s not that you don’t care. It’s that tools to detect issues earlier, faster, and more confidently just haven’t existed.
Until now.
The Solution: HT Vista Scanning in Just 40 Seconds
HT Vista changes everything. In under a minute, this AI-based heat di usion imaging device screens a lump, analyses the results, and gives you — and your client — a clinically backed result (image 1). No needles. No sedation. Just actionable insight.
• 10 seconds of heating
• 30 seconds of cooling
• 1 AI-generated result within 2 minutes
That means your nurses or technicians can handle the scan, and you can focus on treatment decisions. It’s diagnostics, streamlined.

What Does This Mean for Your Clinic?
Yes, HT Vista supports early cancer detection. But let’s be direct: it also boosts your bottom line, with your existing caseload.
A pilot survey conducted by HT Vista revealed that practices using the device reported a 40% increase in mass removal surgeries, with a maximum increase of 200%, without any corresponding increase in the number of dogs requiring lump investigations (table 1).
The ten practices that participated in the study documented the number of lumpectomies they performed in the 3–6 months preceding the use of the HT Vista, and again in the 3–6 months following its introduction into their practice. While the caseload remained consistent, the number of mass removals (and biopsies) that were performed since using the HT Vista rose across all practices.

